Literature DB >> 21444366

Renal function and target organ damage in hypertension.

Luis M Ruilope1, George L Bakris.   

Abstract

Chronic kidney disease (CKD) is frequently observed in patients with arterial hypertension. The same factors that promote the appearance and progression of atherosclerosis can also promote the development of CKD. Two parameters are usually measured to estimate alterations in renal function, the presence of albuminuria, and the estimation of glomerular filtration rate (GFR). Microalbuminuria and a decreased estimated GFR (<60 mL/min/1.73 m(2)) are both accompanied by a significant increase in cardiovascular (CV) risk. Chronic kidney disease can develop all over the cardiorenal continuum and its presence in hypertensive patients with already developed CV disease contributes to a further increase in the development of events and death. Renal protection will in turn obtain CV protection and the treatment to be used is similar to that employed to prevent or to treat established CV disease.

Entities:  

Mesh:

Year:  2011        PMID: 21444366     DOI: 10.1093/eurheartj/ehr003

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  28 in total

Review 1.  Renal sympathetic denervation: applications in hypertension and beyond.

Authors:  Michael Böhm; Dominik Linz; Daniel Urban; Felix Mahfoud; Christian Ukena
Journal:  Nat Rev Cardiol       Date:  2013-06-18       Impact factor: 32.419

2.  Chronic kidney disease: Blood pressure control in CKD--still a matter of debate.

Authors:  Luis M Ruilope
Journal:  Nat Rev Nephrol       Date:  2013-09-10       Impact factor: 28.314

3.  Target organ damage and control of cardiovascular risk factors in hypertensive patients. Evidence from the multicenter ESTher registry.

Authors:  R K Reibis; M Huber; M Karoff; W Kamke; R Kreutz; K Wegscheider; H Völler
Journal:  Herz       Date:  2015-01-30       Impact factor: 1.443

4.  Renin-angiotensin system blockade: time for a reappraisal?

Authors:  Luis M Ruilope
Journal:  Eur Heart J       Date:  2014-04-09       Impact factor: 29.983

Review 5.  Global cardiovascular protection in chronic kidney disease.

Authors:  Gema Ruiz-Hurtado; Pantelis Sarafidis; María S Fernández-Alfonso; Bernard Waeber; Luis M Ruilope
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

6.  Efficacy of single-pill perindopril/indapamide in patients with hypertension and type 2 diabetes.

Authors:  T A Netchessova; A P Shepelkevich; T V Gorbat
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-12-20

7.  Sympathetic renal denervation in hypertension with chronic kidney disease: a case report and review of literature.

Authors:  Yingyi Wu; Suyan Duan; Xuxue Qiang; Zhangcheng Ning; Changying Xing; Bo Zhang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 8.  Current challenges in the clinical management of hypertension.

Authors:  Luis M Ruilope
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

Review 9.  Rethinking hypertensive kidney disease: arterionephrosclerosis as a genetic, metabolic, and inflammatory disorder.

Authors:  Jeffrey B Kopp
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-05       Impact factor: 2.894

Review 10.  Does cardiovascular protection translate into renal protection?

Authors:  Gema Ruiz-Hurtado; Luis M Ruilope
Journal:  Nat Rev Cardiol       Date:  2014-07-08       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.